Mark Erlander

Mark Erlander started their work experience as a Research Fellow at Johnson & Johnson Pharmaceutical Research & Development in 1994. Mark then moved on to become the Chief Scientific Officer (CSO) at Arcturus Bioscience in 2000. After six years, they joined AviaraDx as the CSO in 2006. In 2008, they became the Chief Scientific Officer at bioTheranostics, where they currently hold the position.

Mark Erlander earned their Ph.D. in Neuroscience with an emphasis in Molecular Biology from UCLA. Mark attended the university from 1984 to 1990.